Selective testicular 11beta-HSD inhibitors for the treatment of hypergonadism associated disorders and modulation of fertility
申请人:Morris J. David
公开号:US20070219172A1
公开(公告)日:2007-09-20
Methods for modulating testosterone levels using selective 11β-HSD1-dehydrogenase, 11β-HSD1-reductase and 11β-HSD2 dehydrogenase modulating compounds are described.